Massive sequencing techniques have become routine tools in our group for studying molecular mechanisms of gene expression in this parasite. These tasks are being done in close collaboration with Dr Begoña Aguado (head of the Genomics & Massive Sequencing service at CBMSO). Our group has generated new assemblies, improving previous ones, for the genomes of prototypical Leishmania species like L. infantum, causative agent of visceral leishmaniasis in Spain and other countries around the Mediterranean basin, and L. braziliensis, causing mucocutaneous leishmaniasis in South America. For hosting this information, which is actively curated, a web page was created: http://leish-esp.cbm.uam.es. Furthermore, we are using massive RNA sequencing (RNA-seq) for the annotation of transcriptomes of several Leishmania species and to study changes in gene expression. Thus, RNA-seq was used to determine genes involved in parasite resistance against the drugs currently available for treatment of human leishmaniasis. Additionally, we are looking for regulatory cis-elements, often found in the 3’ untranslated regions (UTRs) of mRNAs, associated with RNA-binding proteins (RBPs), as key players in the regulation of gene expression.

Another area of active research, headed by Dr Manuel Soto, is aimed to the study of Leishmania – host immune response interactions, towards the development of prophylactic tools for preventing Leishmania infection. In this regards, a genetically modified-Leishmania mutant line (LiΔHSP70-II) is being analyzed as a promising vaccine; its inoculation induces memory and effector T cell responses against Leishmania able to control subsequent challenges. Finally, as members of the Tropical Diseases network, our group is engaged in collaborative research activities with different national health institutions.